vTv Therapeutics Inc.VTVTNASDAQ
Loading
VTVT Revenue Growth (YoY Quarterly)•-241.18%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
-241.18%
-241.2pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+45.96%
-1.7pp
+45.96%
-1.7pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | -100.00% | +0.00% | +0.00% | -241.18% |
| Gross Profit Growth | +0.00% | -100.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +176.79% | +58.95% | +2.87% | +47.64% | +45.96% |
| Weighted Average Shares Diluted Growth | +176.79% | +58.95% | +2.87% | +47.64% | +45.96% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -39.22% | -100.00% | -100.00% | -100.00% | -100.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +247.30% | -40.89% | -43.07% | +130.50% | +134.93% |
| Book Value per Share Growth | +0.00% | -76.04% | -83.70% | +218.36% | +261.88% |
| Debt Growth | -68.05% | -58.05% | -69.14% | +69.01% | -100.00% |
| R&D Expense Growth | +4.49% | +6.83% | +19.31% | +117.74% | +74.80% |
| SG&A Expenses Growth | +4.13% | -7.67% | -2.64% | +12.10% | +48.67% |
1 / 4